The role of sialic acid and galactose residues in determining the survival of human plasma alpha-antitrypsin in the blood circulation.
D002241:Carbohydrates / Q000032:analysis; D002918:Chymotrypsin / Q000037:antagonists & inhibitors; D004355:Drug Stability; D005693:Galactosemias; D006207:Half-Life; D006801:Humans; D005779:Immunodiffusion; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D009439:Neuraminidase; D009928:Organ Specificity; D012794:Sialic Acids / Q000097:blood; D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin / Q000378:metabolism
D002241:Carbohydrates; D012794:Sialic Acids; D014361:Trypsin Inhibitors; D000515:alpha 1-Antitrypsin; D009439:Neuraminidase; D002918:Chymotrypsin